Literature DB >> 18502341

Anaplastic thyroid cancer.

Ryan L Neff1, William B Farrar, Richard T Kloos, Kenneth D Burman.   

Abstract

Anaplastic thyroid cancer is an uncommon, typically lethal malignancy of older adults with no effective systemic therapy. The mean survival time is usually less than 6 months from the time of diagnosis and, unfortunately, this outcome is not fundamentally altered by available treatments. Histologic tissue confirmation is recommended if the diagnosis is not absolutely certain to exclude tumors with better prognosis or that require different treatment. Patency of the airway should be kept in mind throughout the patient's course and individuals with impending airway obstruction, in the absence of imminent death from other sites of disease, should be considered for a tracheostomy to secure the airway. Enrollment in meaningful clinical trials should be given the highest priority at all decision points.

Entities:  

Mesh:

Year:  2008        PMID: 18502341     DOI: 10.1016/j.ecl.2008.02.003

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  49 in total

1.  Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraft.

Authors:  Manoj Garg; Ryoko Okamoto; Yasunobu Nagata; Deepika Kanojia; Subhashree Venkatesan; Anand M T; Glenn D Braunstein; Jonathan W Said; Ngan B Doan; Quoc Ho; Tadayuki Akagi; Sigal Gery; Li-Zhen Liu; Kar Tong Tan; Wee Joo Chng; Henry Yang; Seishi Ogawa; H Phillip Koeffler
Journal:  J Clin Endocrinol Metab       Date:  2014-11-03       Impact factor: 5.958

Review 2.  Pharmacotherapy options for advanced thyroid cancer: a systematic review.

Authors:  Christian Lerch; Bernd Richter
Journal:  Drugs       Date:  2012-01-01       Impact factor: 9.546

3.  Anaplastic Thyroid Carcinoma, Version 2.2015.

Authors:  Robert I Haddad; William M Lydiatt; Douglas W Ball; Naifa Lamki Busaidy; David Byrd; Glenda Callender; Paxton Dickson; Quan-Yang Duh; Hormoz Ehya; Megan Haymart; Carl Hoh; Jason P Hunt; Andrei Iagaru; Fouad Kandeel; Peter Kopp; Dominick M Lamonica; Judith C McCaffrey; Jeffrey F Moley; Lee Parks; Christopher D Raeburn; John A Ridge; Matthew D Ringel; Randall P Scheri; Jatin P Shah; Robert C Smallridge; Cord Sturgeon; Thomas N Wang; Lori J Wirth; Karin G Hoffmann; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2015-09       Impact factor: 11.908

4.  Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer.

Authors:  Avaniyapuram Kannan Murugan; Ermal Bojdani; Mingzhao Xing
Journal:  Biochem Biophys Res Commun       Date:  2010-02-18       Impact factor: 3.575

Review 5.  Novel approaches in anaplastic thyroid cancer therapy.

Authors:  Kun-Tai Hsu; Xiao-Min Yu; Anjon W Audhya; Juan C Jaume; Ricardo V Lloyd; Shigeki Miyamoto; Tomas A Prolla; Herbert Chen
Journal:  Oncologist       Date:  2014-09-26

6.  Anaplastic thyroid carcinoma presenting as bilateral pleural effusion.

Authors:  R Sodhi; G Sindhwani; S Chandra; D Anand
Journal:  Lung India       Date:  2014-07

7.  Antiproliferative effect of chrysin on anaplastic thyroid cancer.

Authors:  TramAnh Phan; Xiao-Min Yu; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  J Surg Res       Date:  2011-04-20       Impact factor: 2.192

8.  Microarray analysis of papillary thyroid cancers in Korean.

Authors:  Hyun Sook Kim; Do Hyung Kim; Ji Yeon Kim; Nam Ho Jeoung; In Kyu Lee; Jin Gu Bong; Eui Dal Jung
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 2.884

9.  Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation.

Authors:  S Jang; X-M Yu; S Odorico; M Clark; R Jaskula-Sztul; C M Schienebeck; K R Kupcho; A D Harrison; G N Winston-McPherson; W Tang; H Chen
Journal:  Cancer Gene Ther       Date:  2015-08-07       Impact factor: 5.987

10.  FNA of misclassified primary malignant neoplasms of the thyroid: Impact on clinical management.

Authors:  Sejal S Shah; William C Faquin; Roberto Izquierdo; Kamal K Khurana
Journal:  Cytojournal       Date:  2009-01-19       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.